Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective
Saved in:
| Published in: | Health Economics Review |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|